These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4045729)

  • 1. Serotonergic prejunctional inhibition of canine coronary adrenergic nerves.
    Cohen RA
    J Pharmacol Exp Ther; 1985 Oct; 235(1):76-80. PubMed ID: 4045729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurogenic cholinergic prejunctional inhibition of sympathetic beta adrenergic relaxation in the canine coronary artery.
    Cohen RA; Shepherd JT; Vanhoutte PM
    J Pharmacol Exp Ther; 1984 May; 229(2):417-21. PubMed ID: 6325664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the prejunctional inhibitory action of 5-hydroxytryptamine on noradrenergic transmission with neuronal amine uptake in rabbit isolated ear artery.
    Meehan AG; Story DF
    J Pharmacol Exp Ther; 1989 Jan; 248(1):342-7. PubMed ID: 2913279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenine nucleotides and 5-hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery.
    Cohen RA
    J Clin Invest; 1986 Feb; 77(2):369-75. PubMed ID: 3003158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of adrenergic neurotransmission in canine tibial artery after exposure to 5-hydroxytryptamine in vitro.
    Cohen RA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):493-9. PubMed ID: 3039118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prejunctional and postjunctional actions of endogenous norepinephrine at the sympathetic neuroeffector junction in canine coronary arteries.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Circ Res; 1983 Jan; 52(1):16-25. PubMed ID: 6129074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-induced neurogenic coronary contractions due to accumulation of the false neurotransmitter, 5-hydroxytryptamine.
    Cohen RA
    J Clin Invest; 1985 Jan; 75(1):286-92. PubMed ID: 3965509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
    Kahan T
    Acta Physiol Scand Suppl; 1987; 560():1-38. PubMed ID: 2884804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML; Schenck KW; Hemrick-Luecke SH
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prejunctional adrenergic inhibition by aggregating platelets in canine blood vessels.
    Lorenz RR; Vanhoutte PM
    Am J Physiol; 1985 Sep; 249(3 Pt 2):H685-9. PubMed ID: 4037113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition by ergonovine of norepinephrine release in the coronary artery and saphenous vein of the dog.
    O'Rourke ST; Vanhoutte PM
    J Pharmacol Exp Ther; 1989 Apr; 249(1):52-5. PubMed ID: 2709336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
    Van Nueten JM; Janssen PA; Van Beek J; Xhonneux R; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the adrenergic transmitter on epicardial coronary arteries.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Fed Proc; 1984 Nov; 43(14):2862-6. PubMed ID: 6386529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ; Moret C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog.
    Verbeuren TJ; Jordaens FH; Herman AG
    J Pharmacol Exp Ther; 1983 Aug; 226(2):579-88. PubMed ID: 6875866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins.
    Curro FA; Greenberg S; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1978 Dec; 207(3):936-49. PubMed ID: 215746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-hydroxytryptamine and precapillary vessels.
    Van Nueten JM
    Fed Proc; 1983 Feb; 42(2):223-7. PubMed ID: 6295823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of 5-hydroxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimal damage in vivo.
    Cohen RA; Zitnay KM; Weisbrod RM
    Circ Res; 1987 Dec; 61(6):829-33. PubMed ID: 3677339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the tricyclic antidepressant amitriptyline with prejunctional alpha and muscarinic receptors in the dog saphenous vein.
    Collis MG; Shepherd JT
    J Pharmacol Exp Ther; 1980 Jun; 213(3):616-22. PubMed ID: 6259320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.